Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emeline Colomba

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Clinical Genitourinary Cancer|October 24, 2021
Activity of Systemic Treatments After Cabozantinib Failure in Advanced Metastatic Renal Cell CarcinomaLuigi Cerbone, Vincenzo Di Nunno, Lucia Carril Ajuria, et al.
European Urology Oncology|November 11, 2025
PARP Inhibitors in Metastatic Castration-resistant Prostate Cancer: Rationale, Mechanisms, and Clinical ApplicationsStéphane Oudard, Marc-Olivier Timsit, Denis Maillet, et al.
Frontiers in Immunology|November 10, 2022
Immune-related arthritis following pelvic radiation therapy in a patient with lung cancer receiving long-term immune checkpoint blocker treatment: Case reportMihaela Aldea, Rakiba Belkhir, Emeline Colomba, et al.
Prostate Cancer and Prostatic Diseases|June 20, 2025
Case series exploring hormonal sensitivity in prostate cancer patients harboring the germline African-ancestry HOXB13 X285K variantMayuko Kanayama, Emeline Colomba, Yusra Shao, et al.
Journal of Cachexia, Sarcopenia and Muscle|July 29, 2022
Weight and skeletal muscle loss with cabozantinib in metastatic renal cell carcinomaEmeline Colomba, Carolina Alves Costa Silva, Gwénaël Le Teuff, et al.
The Oncologist|February 8, 2021
The Effect of Concomitant Proton Pump Inhibitor and Cabozantinib on the Outcomes of Patients with Metastatic Renal Cell CarcinomaElie Rassy, Luigi Cerbone, Edouard Auclin, et al.
Frontiers in Oncology|May 20, 2026
High prevalence of targetable drivers but poor outcomes in lung adenocarcinoma: a real-world cohort from the French West IndiesRégine Marlin, Emeline Colomba, Sabrina Pennont, et al.
Bulletin Du Cancer|November 22, 2021
[Intercontinental Multidisciplinary Oncology Videoconferencing between the South Pacific and the French mainland: Results after one year and 323 cases of rare or complex cancers discussed]Charles Honoré, Gianmaria Drovetti, Arthur Geraud, et al.
Biomarker Research|October 20, 2023
Circulating Tumor DNA from Ascites as an alternative to tumor sampling for genomic profiling in ovarian cancer patientsMaria Kfoury, Reda El Hazzaz, Claire Sanson, et al.
The Journal of Molecular Diagnostics : JMD|November 20, 2012
Detection of BRAF p.V600E mutations in melanomas: comparison of four methods argues for sequential use of immunohistochemistry and pyrosequencingEmeline Colomba, Zofia Hélias-Rodzewicz, Andreas Von Deimling, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Clinical Genitourinary Cancer|October 24, 2021
Activity of Systemic Treatments After Cabozantinib Failure in Advanced Metastatic Renal Cell CarcinomaLuigi Cerbone, Vincenzo Di Nunno, Lucia Carril Ajuria, et al.
European Urology Oncology|November 11, 2025
PARP Inhibitors in Metastatic Castration-resistant Prostate Cancer: Rationale, Mechanisms, and Clinical ApplicationsStéphane Oudard, Marc-Olivier Timsit, Denis Maillet, et al.
Frontiers in Immunology|November 10, 2022
Immune-related arthritis following pelvic radiation therapy in a patient with lung cancer receiving long-term immune checkpoint blocker treatment: Case reportMihaela Aldea, Rakiba Belkhir, Emeline Colomba, et al.
Prostate Cancer and Prostatic Diseases|June 20, 2025
Case series exploring hormonal sensitivity in prostate cancer patients harboring the germline African-ancestry HOXB13 X285K variantMayuko Kanayama, Emeline Colomba, Yusra Shao, et al.
Journal of Cachexia, Sarcopenia and Muscle|July 29, 2022
Weight and skeletal muscle loss with cabozantinib in metastatic renal cell carcinomaEmeline Colomba, Carolina Alves Costa Silva, Gwénaël Le Teuff, et al.
The Oncologist|February 8, 2021
The Effect of Concomitant Proton Pump Inhibitor and Cabozantinib on the Outcomes of Patients with Metastatic Renal Cell CarcinomaElie Rassy, Luigi Cerbone, Edouard Auclin, et al.
Frontiers in Oncology|May 20, 2026
High prevalence of targetable drivers but poor outcomes in lung adenocarcinoma: a real-world cohort from the French West IndiesRégine Marlin, Emeline Colomba, Sabrina Pennont, et al.
Bulletin Du Cancer|November 22, 2021
[Intercontinental Multidisciplinary Oncology Videoconferencing between the South Pacific and the French mainland: Results after one year and 323 cases of rare or complex cancers discussed]Charles Honoré, Gianmaria Drovetti, Arthur Geraud, et al.
Biomarker Research|October 20, 2023
Circulating Tumor DNA from Ascites as an alternative to tumor sampling for genomic profiling in ovarian cancer patientsMaria Kfoury, Reda El Hazzaz, Claire Sanson, et al.
The Journal of Molecular Diagnostics : JMD|November 20, 2012
Detection of BRAF p.V600E mutations in melanomas: comparison of four methods argues for sequential use of immunohistochemistry and pyrosequencingEmeline Colomba, Zofia Hélias-Rodzewicz, Andreas Von Deimling, et al.
Pageof 7